Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-23-024761
Filing Date
2023-03-30
Accepted
2023-03-30 17:25:53
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea175874-s3_pasitheathe.htm S-3 222955
2 OPINION OF LOWENSTEIN SANDLER LLP ea175874ex5-1_pasitheathe.htm EX-5.1 21716
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea175874ex23-1_pasitheathe.htm EX-23.1 2546
4 FILING FEE TABLE ea175874ex-fee_pasitheathe.htm EX-FILING FEES 17416
5 GRAPHIC image_001.jpg GRAPHIC 5408
6 GRAPHIC ex5-1_001.jpg GRAPHIC 4330
7 GRAPHIC ex5-1_002.jpg GRAPHIC 5733
  Complete submission text file 0001213900-23-024761.txt   287285
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

EIN.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-271010 | Film No.: 23781899
SIC: 2834 Pharmaceutical Preparations